Infinity Pharmaceuticals | INFI - Pre Tax Profit


Infinity Pharmaceuticals reported $-9.96M in Pre-Tax Profit for its fiscal quarter ending in June of 2023.





Pre Tax Profit Change Date
AbbVie USD 4.38B 1.92B Sep/2025
Alterity Therapeutics Limited AUD -4.74M 3.53M Dec/2024
Amgen USD 3.92B 2.35B Sep/2025
AstraZeneca USD 3.24B 117M Sep/2025
Bristol-Myers Squibb USD 3.11B 1.34B Sep/2025
Cipla INR 11.69B 6.85B Dec/2025
Clal Biotechnology ILS 86.82M 17.9M Dec/2022
Compugen USD -6.94M 421K Sep/2025
CSL USD 1.4B 1.14B Jun/2025
Eisai JPY 22B 7.47B Dec/2025
Eli Lilly USD 7.23B 456M Sep/2025
Gilead Sciences USD 3.64B 1.21B Sep/2025
GlaxoSmithKline GBP 1.23B 1.23B Dec/2025
Grifols EUR 66.98M 19.92M Jun/2024
Incyte USD 389.94M 92.37M Dec/2025
Infinity Pharmaceuticals USD -9.96M 1.09M Jun/2023
Ionis Pharmaceuticals USD -129M 253M Sep/2025
J&J USD 4.97B 2.53B Dec/2025
Novartis USD 4.2B 335M Sep/2025
Pfizer USD 3.33B 290M Sep/2025
Roche Holding CHF 4.79B 3.01B Jun/2025
TG Therapeutics USD 25.91M 5.01M Sep/2025